Three details:
1. Apixio uses machine learning and text analytics to mine, compile and analyze large volumes of disparate and unstructured patient data to better support payers and providers’ administrative activities.
2. The transaction is expected to close by the end of 2020.
3. Once the deal closes, Apixio will remain an independent entity as part of Centene’s Health Care Enterprises group.
More articles on data analytics:
Microsoft-backed data alliance awards $1.2M for 3 cancer treatment innovation projects
El Paso’s record COVID-19 numbers were inaccurate, health director expects more issues: 4 details
Michigan governor signs law expanding nursing home COVID-19 data reporting
